Shock and emotion: the parental perspective of eye disease

A recent Australian survey has found many parents are shocked to learn their children have vision problems and struggle with a range of issues and emotions...

New device to fix retinal tears

US-based ophthalmic device manufacturer BVI has launched CryoTreq, a single-use, handheld cryo-surgery device it claims will “revolutionise” retinal tear...

Worrying results from Welcome to School study

Uncorrected refractive errors account for up to 96% of visual impairment in school-aged children and are associated with amblyopia and strabismus development,...

A breathalyser for Covid-19?

Ohio State University researchers are testing a new breathalyser that could act as a cheap, quick and more patient-friendly test for Covid-19 compared...

VR surgery trainees, caffeine and beta blockers

A joint US-Brazilian study has shown coffee hinders the performance of new vitreoretinal (VR) surgeons, while beta blockers may improve it.

oDocs’ inaugural award winner

Innovative eye care technology enterprise oDocs Eye Care has awarded it’s first oDocs Project Grant Award to fifth year Otago medical student Aqeeda Singh....

Art and optics: The beautiful and the curious

The British Optical Association Museum’s latest exhibition, Pathos Ocularis - The Beautiful and the Curious, was inspired by artist Iluá Hauck da Silva’s...

Optometrist wins lockdown photo comp

Auckland optometrist Jeremy Wong was one of six winners announced in New Zealand photographer Chris McLennan’s lockdown photo challenge, #CMflattenthecurve,...

Focusing on preventable eye injuries

The Royal Australia and New Zealand College of Ophthalmology’s (RANZCO’s) Australian and New Zealand Eye Foundation (ANZEF) has launched JulEYE, a campaign...

New RANZCO president announced

RANZCO has announced Professor Nitin Verma will be the next president, replacing Dr Heather Mack when her term ends on 10 October. Prof Verma is a long-standing...

New RP2 gene therapy for RP

Scientists have developed a new gene therapy approach that could treat retinitis pigmentosa (RP).

Cornea research update

CXL-assisted infection reduction: a randomised clinical trial evaluating the effect of adjuvant CXL on outcomes in fungal keratitis

812 articles found

Bottom Banner Advert